Literature DB >> 7805769

Chronic D-fenfluramine decreases serotonin transporter messenger RNA expression in dorsal raphe nucleus.

M Rattray1, G Wotherspoon, D Savery, S Baldessari, C Marden, J V Priestley, C Bendotti.   

Abstract

In situ hybridization was used to measure the effects of chronic fenfluramine administration on serotonin transporter messenger RNA expression in cells of the dorsal raphe nucleus complex. Fenfluramine produced a significant, but transient, down-regulation of serotonin transporter mRNA in cells which lie in the ventral portion of the dorsal raphe nucleus, but not in the dorsal part of the dorsal raphe nucleus. Our findings suggest that cells which lie in the ventral part of the dorsal raphe nucleus are more sensitive to the effects of chronic fenfluramine administration, but that fenfluramine does not cause long-term changes in gene expression in serotonin cell bodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805769     DOI: 10.1016/0922-4106(94)90070-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Long-term regulation of neuronal high-affinity glutamate and glutamine uptake in Aplysia.

Authors:  J Levenson; S Endo; L S Kategaya; R I Fernandez; D G Brabham; J Chin; J H Byrne; A Eskin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Constitutive expression of calmodulin-binding phosphoprotein GAP-43 in rat serotonergic and noradrenergic cell groups which project to the spinal cord.

Authors:  G Wotherspoon; J J López-Costa; G J Michael; J V Priestley
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 3.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.